Anti-CA125 [20E3], Rabbit IgG, kappa
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format for improved compatibility with existing reagents assays and techniques. |
Anti-IL-8 [WS-4], Rabbit IgG, kappa
| Applications | ELISA, IHC, Neutralize |
| Reactivities | Human, Rabbit |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-DOG1 [19F2], Rabbit IgG, kappa
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format for improved compatibility with existing reagents assays and techniques. |
Anti-CD3e [33H1], Rabbit IgG, kappa
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Anti-Glypican 3 [4G7], Rabbit IgG, kappa
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-MSH2 [1B11-14-16], Rabbit IgG, kappa
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format for improved compatibility with existing reagents assays and techniques. |
Anti-Glypican 3 [15G1], Rabbit IgG, kappa
| Applications | ELISA, FC, IHC |
| Reactivities | Human, Monkey, Rat |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-GFAP [10G1G11H7], Rabbit IgG, kappa
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-Cytokeratin 20 [10A2], Rabbit IgG, kappa
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Recombinant Anti-LeY (Clone BR96)
| Applications | ELISA, IHC |
| Reactivities | Human |
Recombinant Anti-GM2 ganglioside (Clone L55-81)
| Applications | ELISA, IHC |
| Reactivities | Human |
Anti-PSMA [11d1e5E10], Rabbit IgG, kappa
| Applications | ELISA, IHC |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-Cytokeratin 14 [2G4], Rabbit IgG, kappa
| Applications | ELISA, IHC |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-p40 [14D5E8F12], Rabbit IgG, kappa
| Applications | ELISA, IHC |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-Alpha actin 1 [3G8C7A6], Rabbit IgG, kappa
| Applications | ELISA, IHC |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format for improved compatibility with existing reagents assays and techniques. |
United States
Germany
Japan
United Kingdom
China